Tests how repeatable a special MRI scan is for tumors
Part of Cancer clinical trials.
This study checks whether a specialized MRI using injected “hyperpolarized pyruvate” gives consistent tumor images when repeated. It may help future patients by improving how reliably this scan can measure tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed solid cancer diagnosis (pathology-confirmed), with limited exceptions for brain lesions
- Your tumor can be measured/evaluated on scan, with a visible tumor area larger than 1 cm long
- You must be in one of the allowed cancer groups: sarcoma, prostate, breast, brain, metastatic cancer, or pancreatic cancer
- If you can become pregnant, you must have a negative blood/urine pregnancy test within 2 weeks before the scan
- You must be able to receive an IV (a small tube in a vein) and complete the MRI scan
- You must not be breastfeeding and must be able to tolerate the MRI (for example, claustrophobia rules it out)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a labeled nutrient-like molecule ([13C]pyruvate) to create clearer MRI images. It’s for healthy volunteers and helps researchers understand how well this imaging agent works.
This early-phase study tests whether a special MRI scan with injected labeled “pyruvate” can act as a biomarker (a measurable sign) for advanced solid tumor activity. It may help doctors see tumor metabolism over time and better track how treatment is affecting cancer.
This trial uses a special MRI scan that shows how “metabolism” (how cells use fuel) differs in brain tumors. It may help researchers better understand tumor biology and how tumors may respond to treatment, without using chemotherapy or radiation as part of the study.
This early study tests how well MRI (a type of scan) can help measure a substance related to tumors. If you already have cancer and are able to have an MRI scan, you may be able to take part.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
This trial tests whether a specialized MRI scan using a pyruvate tracer can better detect high-grade (more aggressive) prostate cancer. It may help doctors find cancer more accurately and guide treatment decisions or targeted follow-up.
Hear when a new Malignant Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.